What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Mutation
Michael J. Ackerman spends much of his time researching Internal medicine, Long QT syndrome, Cardiology, Sudden death and QT interval.
His work in Internal medicine addresses subjects such as Endocrinology, which are connected to disciplines such as Ryanodine receptor.
The Long QT syndrome study combines topics in areas such as Genetics, Genetic testing, Catecholaminergic polymorphic ventricular tachycardia, Sodium channel and Autopsy.
The concepts of his Cardiology study are interwoven with issues in Guideline and Hazard ratio.
His Sudden death research focuses on subjects like Pathology, which are linked to Troponin T.
His QT interval research integrates issues from Electrocardiography, Retrospective cohort study, Pediatrics and Risk factor.
His most cited work include:
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) (1076 citations)
- Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation (850 citations)
- Truncations of Titin Causing Dilated Cardiomyopathy (783 citations)
What are the main themes of his work throughout his whole career to date?
Michael J. Ackerman mainly focuses on Internal medicine, Cardiology, Long QT syndrome, QT interval and Sudden cardiac death.
His work is dedicated to discovering how Internal medicine, Endocrinology are connected with Sodium channel and other disciplines.
His work on Electrocardiography, Ventricular tachycardia, Heart disease and Ventricular fibrillation as part of general Cardiology research is frequently linked to In patient, thereby connecting diverse disciplines of science.
His study on Long QT syndrome also encompasses disciplines like
- Genetics together with Brugada syndrome,
- Genetic testing which connect with Intensive care medicine.
His QT interval study incorporates themes from Hazard ratio and Heart rate.
His Sudden cardiac death study integrates concerns from other disciplines, such as Sudden cardiac arrest, Athletes and Disease.
He most often published in these fields:
- Internal medicine (50.63%)
- Cardiology (39.63%)
- Long QT syndrome (32.13%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (50.63%)
- Cardiology (39.63%)
- Long QT syndrome (32.13%)
In recent papers he was focusing on the following fields of study:
Michael J. Ackerman mostly deals with Internal medicine, Cardiology, Long QT syndrome, Sudden cardiac death and Hypertrophic cardiomyopathy.
His work in the fields of Internal medicine, such as Catecholaminergic polymorphic ventricular tachycardia, Interquartile range, Cohort and Sudden death, overlaps with other areas such as In patient.
The study incorporates disciplines such as Retrospective cohort study and Heart rate in addition to Cardiology.
His Long QT syndrome study is concerned with the larger field of QT interval.
The Sudden cardiac death study combines topics in areas such as Implantable cardioverter-defibrillator, Brugada syndrome, Family medicine, Sudden cardiac arrest and Pediatrics.
As a part of the same scientific study, Michael J. Ackerman usually deals with the Hypertrophic cardiomyopathy, concentrating on Cardiomyopathy and frequently concerns with Dilated cardiomyopathy, Context and Intensive care medicine.
Between 2017 and 2021, his most popular works were:
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). (210 citations)
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (179 citations)
- 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy (148 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
His scientific interests lie mostly in Internal medicine, Cardiology, Long QT syndrome, Sudden cardiac death and Sudden death.
His research in Internal medicine tackles topics such as MEDLINE which are related to areas like Death sudden cardiac.
His Cardiology research is multidisciplinary, incorporating perspectives in Retrospective cohort study and K channels.
His Long QT syndrome study improves the overall literature in QT interval.
His Sudden cardiac death research is multidisciplinary, incorporating elements of Implantable cardioverter-defibrillator, Sudden cardiac arrest, Brugada syndrome and Ventricular fibrillation.
His biological study spans a wide range of topics, including Channelopathy, Evidence-based practice and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
